NASDAQ · Biotechnology

ACET (ACET) Stock

$8.30 +1.22% NASDAQ: ACET Healthcare

Valuation

MetricValue
Price$8.30
Market Cap$77.59M
P/E Ratio-0.46
P/B Ratio0.46
P/S Ratio0.00
EPS (TTM)$-16.95
52-Week High$17.44
52-Week Low$6.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-73.58%
ROA-60.94%
ROCE-76.73%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.10
Current Ratio7.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$25.0M$0$0$0
Operating Profit$-61.0M$-73.0M$-152.0M$-128.0M$-122.0M
Net Profit$-62.0M$-70.0M$-143.0M$-117.0M$-117.0M
EPS$-32.00$-27.20$-52.96$-21.28$-16.95
Op Margin-631.4%-290.3%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$339.0M$331.0M$207.0M$220.0M$192.0M
Total Liabilities$36.0M$38.0M$37.0M$34.0M$33.0M
Cash$278.0M$258.0M$160.0M$56.0M$39.0M
Borrowings$21.0M$21.0M$21.0M$17.0M$15.0M

Latest News

Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? Zacks · Jul 1, 2026 Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology PR Newswire · Jun 29, 2026 Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference MarketBeat · Jun 4, 2026 Are Medical Stocks Lagging Adicet Bio (ACET) This Year? Zacks · May 28, 2026 Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade Zacks · May 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-51.0M$-45.0M$-94.0M$-92.0M$-95.0M
Investing Cash Flow$-16.0M$-34.0M$-9.0M$-120.0M$1.0M
Financing Cash Flow$5.0M$-2.0M$0$0$0
Net Cash Flow$189.0M$-20.0M$-98.0M$-100.0M$-18.0M
Free Cash Flow$-64.0M$-62.0M$-98.0M$-93.0M$-97.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-126.30%
Quick Ratio7.65
Interest Coverage—
Return 1Y-29.46%
Return 3Y-82.55%
Return 5Y-93.11%

Ownership

Insiders Held1.08%
Institutions Held63.33%
Institutions Float Held64.02%
Institutional HolderSharesReport Date
RA Capital Management, L.P.1,182,6242026-03-31
Orbimed Advisors LLC.1,027,9442026-03-31
Franklin Resources, Inc.626,5712026-03-31
Citadel Advisors Llc381,8232026-03-31
Vanguard Capital Management LLC336,5242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
GANX $1.73 -6.99% -2.70 $73.79M 0.00%
HOWL $0.40 -3.04% -0.33 $19.54M 0.00%

About ACET

ACET is led by CEO Chen Schor, employs 152 people, headquartered in US, publicly traded since 2018.

ACET stock trades at $8.30 with a market capitalization of $77.59M. The stock is valued at a price-to-earnings (P/E) ratio of -0.46, price-to-book of 0.46, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $6.01 and $17.44, and currently trades 52.4% below its 52-week high.

On profitability, ACET generates a return on equity (ROE) of -73.58%, return on capital employed of -76.73%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides